P19-54 LB. Interrogating the membrane-proximal external region (MPER) of HIV-1 gp140

por Jeffs, S, Durham, N, Arias, M, Van Roey, G, Shattock, R
Publicado 2009

P04-30. Sorting of infectious and non-infectious viral particles by Env-specific mAb

por Stieh, DJ, Fischetti, L, Buff, V, Armanasco, N, Shattock, R
Publicado 2009

P02-03. Screening of potential adjuvants for induction of pro-IgA factors

por Buffa, V, Klein, K, Tregoning, J, Siddiqui, A, Shattock, R
Publicado 2009

P04-33. Mechanisms of HIV-1 antibody mediated inhibition in Monomac-1 and MDM

por Fischetti, L, Stieh, D, Fahrbach, K, Buffa, V, Hope, T, Shattock, R
Publicado 2009

Optimising the collection of female genital tract fluid for cytokine analysis in pregnant women

por Short, C.S., Quinlan, R., Bennett, P., Shattock, R.J., Taylor, G.P.
Publicado 2018

P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140

por Morrow, RJ, Donnelly, L, Curran, RM, Malcolm, RK, Woolfson, AD, Andrews, GP, Shattock, R
Publicado 2009

Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen()

por Mann, J.F.S., Stieh, D., Klein, K., de Stegmann, D.S. Miranda, Cranage, M.P., Shattock, R.J., McKay, P.F.
Publicado 2012

P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein

por Cranage, M, Fraser, C, Cope, A, McKay, P, Elsley, W, Page, M, Mahmoud, AN, DaCosta, K, Fletcher, P, Armanasco, N, Almond, N, Shattock, R
Publicado 2009

P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine

por Lewis, DJ, Lacey, CJ, Jeffs, S, Cole, T, Fraser, C, Wiggins, R, Woodrow, M, Cope, A, Cai, C, Giemza, E, Mahmhoud, A, Katinger, D, Cranage, M, Shattock, R
Publicado 2009

Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial

por Haidari, G., Cope, A., Miller, A., Venables, S., Yan, C., Ridgers, H., Reijonen, K., Hannaman, D., Spentzou, A., Hayes, P., Bouliotis, G., Vogt, A., Joseph, S., Combadiere, B., McCormack, S., Shattock, R. J.
Publicado 2017

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization

por Katinger, D, Jeffs, S, Altmann, F, Cope, A, McKay, P, Almond, N, Sandström, E, Hejdeman, B, Biberfeld, G, Nilsson, C, Hallengärd, D, Wahren, B, Lehner, T, Singh, M, Lewis, DJ, Lacey, C, Shattock, R
Publicado 2012

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life

por Yates, N L, Stacey, A R, Nolen, T L, Vandergrift, N A, Moody, M A, Montefiori, D C, Weinhold, K J, Blattner, W A, Borrow, P, Shattock, R, Cohen, M S, Haynes, B F, Tomaras, G D
Publicado 2013

Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets

por McKay, P F, Zhou, J, Frise, R, Blakney, A K, Bouton, C R, Wang, Z, Hu, K, Samnuan, K, Brown, J C, Kugathasan, R, Yeow, J, Stevens, M M, Barclay, W S, Tregoning, J S, Shattock, R J
Publicado 2022

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

por Katinger, D, Wagner, A, Luque, I, Crespillo, S, Conejero-Lara, F, Roger, M, Martin, C, Mouz, N, Mourao, S, Farsang, A, Notka, F, Malcolm, K, Bosquet, N, Le Grand, R, Moog, C, Cope, A, Shattock, R, Lewis, DJ, El Habib, R
Publicado 2012

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa—study protocol for a mixed-methods study...

por Nash, S., Dietrich, J., Ssemata, A. S., Herrera, C., O’Hagan, K., Else, L., Chiodi, F., Kelly, C., Shattock, R., Chirenje, M., Lebina, L., Khoo, S., Bekker, L-G, Weiss, H. A., Gray, C., Stranix-Chibanda, L., Kaleebu, P., Seeley, J., Martinson, N., Fox, J.
Publicado 2020

Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates

por Reiss, E. I. M. M., van Haaren, M. M., van Schooten, J., Claireaux, M. A. F., Maisonnasse, P., Antanasijevic, A., Allen, J. D., Bontjer, I., Torres, J. L., Lee, W-H, Ozorowski, G., Vázquez Bernat, N., Kaduk, M., Aldon, Y., Burger, J. A., Chawla, H., Aartse, A., Tolazzi, M., Gao, H., Mundsperger, P., Crispin, M., Montefiori, D. C., Karlsson Hedestam, G. B., Scarlatti, G., Ward, A. B., Le Grand, R., Shattock, R., Dereuddre-Bosquet, N., Sanders, R. W., van Gils, M. J.
Publicado 2022